Antibodies are a successful class of therapeutic agents ... Following the success of the first generation of monoclonal antibody blockbusters, second-generation antibodies were recently approved.

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Therapeutic monoclonal antibodies (mAbs) are potent new tools for a molecular targeted approach to modify the course of multiple sclerosis (MS). Besides natalizumab, which was approved in 2006 ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

By Tarun Sai Lomte A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in mouse models. Could they help eliminate malaria in the future?

The pharmaceutical landscape is undergoing a dramatic transformation. New modalities are reshaping what's possible in drug development, from monoclonal antibodies to RNA therapies, from small ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

Monoclonal antibodies (mAbs ... and pharmacokinetics of an inhaled antibody therapy for COVID-19. They developed IN-006, a reformulation of regdanvimab, which is an IV-dosed mAb targeting the ...